世界の上気道感染症治療市場2024-2028

◆英語タイトル:Global Upper Respiratory Tract Infection Treatment Market 2024-2028

Technavioが発行した調査報告書(IRTNTR43396-23)◆商品コード:IRTNTR43396-23
◆発行会社(リサーチ会社):Technavio
◆発行日:2023年10月17日
◆ページ数:約120
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:北米、ヨーロッパ、アジア、その他地域
◆産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥370,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥592,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行・送付致します。(請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

世界の上気道感染症治療市場 2024〜2028年上気道感染症治療市場は、2023年から2028年の間に26億6,115万米ドルで成長し、予測期間中のCAGRは4.21%で加速すると予測されます。当レポートでは、上気道感染症治療市場について、市場規模や予測、動向、成長促進要因、課題などの全体的な分析に加え、約25のベンダーを網羅したベンダー分析も掲載しています。
現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、上気道感染症の罹患率と有病率の上昇、良好な医薬品パイプライン、市販薬の需要増加が牽引しています。

Technavioの上気道感染症治療市場は以下のように区分されます。
タイプ別
- 抗生物質
- 非ステロイド性抗炎症薬および鼻腔充血除去薬
- その他

流通チャネル別
- 病院薬局
- 小売薬局
- オンライン薬局

地域別
- 北米
- ヨーロッパ
- アジア
- その他の地域(ROW)

本調査では、生物学的製剤の出現が今後数年間の上気道感染症治療市場の成長を促進する主な理由の1つであると特定しています。また、上気道感染症を治療するための薬物送達デバイスの開発と治療オプションの技術的進歩は、市場の大きな需要につながるでしょう。

当レポートでは、上気道感染症治療市場について以下の分野をカバーしています。
- 上気道感染症治療市場規模
- 上気道感染症治療市場予測
- 上気道感染症治療市場産業分析

本レポートでは、上気道感染症治療市場の主要ベンダーとして、AstraZeneca Plc、CSL Ltd.、GlaxoSmithKline Plc、MD Total Care LLC、Medtronic Plc、Merck and Co. Inc.、Novartis AG、Parkway Holdings Ltd.、Pfizer Inc.、Regeneron Pharmaceuticals Inc.、Sanofi、Teva Pharmaceutical Industries Ltd.、The Cleveland Clinic Foundation、Yashoda Hospitalsなどを分析しています。また、上気道感染症治療市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。当レポートでは、主要ベンダーの分析に加え、包括的な市場とベンダーの状況を掲載しています。
当調査会社は、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、総括する方法で、市場の詳細な姿を提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

1 エグゼクティブサマリー
2 市場状況
3 市場規模
4 過去の市場規模
5 ファイブフォース分析
6 上気道感染症治療の世界市場:タイプ別市場分析
7 上気道感染症治療の世界市場:流通チャネル別市場分析
8 顧客状況
9 地域別状況
10 推進要因・課題・動向
11 企業状況
12 企業分析
13 付録

❖ レポートの目次 ❖

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2023
o 3.4 Market outlook: Forecast for 2023-2028
o Exhibit 14: Chart on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• 4 Historic Market Size
o 4.1 Global upper respiratory tract infection treatment market 2018 – 2022
o Exhibit 18: Historic Market Size – Data Table on global upper respiratory tract infection treatment market 2018 – 2022 ($ million)
o 4.2 Type Segment Analysis 2018 – 2022
o Exhibit 19: Historic Market Size – Type Segment 2018 – 2022 ($ million)
o 4.3 Distribution Channel Segment Analysis 2018 – 2022
o Exhibit 20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
o 4.4 Geography Segment Analysis 2018 – 2022
o Exhibit 21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
o 4.5 Country Segment Analysis 2018 – 2022
o Exhibit 22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2023 and 2028
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2023 and 2028
• 6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2023-2028 (%)
o Exhibit 31: Data Table on Type – Market share 2023-2028 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Antibiotics – Market size and forecast 2023-2028
o Exhibit 34: Chart on Antibiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 35: Data Table on Antibiotics – Market size and forecast 2023-2028 ($ million)
o Exhibit 36: Chart on Antibiotics – Year-over-year growth 2023-2028 (%)
o Exhibit 37: Data Table on Antibiotics – Year-over-year growth 2023-2028 (%)
o 6.4 NSAIDs and nasal decongestants – Market size and forecast 2023-2028
o Exhibit 38: Chart on NSAIDs and nasal decongestants – Market size and forecast 2023-2028 ($ million)
o Exhibit 39: Data Table on NSAIDs and nasal decongestants – Market size and forecast 2023-2028 ($ million)
o Exhibit 40: Chart on NSAIDs and nasal decongestants – Year-over-year growth 2023-2028 (%)
o Exhibit 41: Data Table on NSAIDs and nasal decongestants – Year-over-year growth 2023-2028 (%)
o 6.5 Others – Market size and forecast 2023-2028
o Exhibit 42: Chart on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 43: Data Table on Others – Market size and forecast 2023-2028 ($ million)
o Exhibit 44: Chart on Others – Year-over-year growth 2023-2028 (%)
o Exhibit 45: Data Table on Others – Year-over-year growth 2023-2028 (%)
o 6.6 Market opportunity by Type
o Exhibit 46: Market opportunity by Type ($ million)
o Exhibit 47: Data Table on Market opportunity by Type ($ million)
• 7 Market Segmentation by Distribution Channel
o 7.1 Market segments
o Exhibit 48: Chart on Distribution Channel – Market share 2023-2028 (%)
o Exhibit 49: Data Table on Distribution Channel – Market share 2023-2028 (%)
o 7.2 Comparison by Distribution Channel
o Exhibit 50: Chart on Comparison by Distribution Channel
o Exhibit 51: Data Table on Comparison by Distribution Channel
o 7.3 Hospital pharmacies – Market size and forecast 2023-2028
o Exhibit 52: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 53: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 54: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 55: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
o 7.4 Retail pharmacies – Market size and forecast 2023-2028
o Exhibit 56: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 57: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 58: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 59: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
o 7.5 Online pharmacies – Market size and forecast 2023-2028
o Exhibit 60: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 61: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
o Exhibit 62: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
o Exhibit 63: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
o 7.6 Market opportunity by Distribution Channel
o Exhibit 64: Market opportunity by Distribution Channel ($ million)
o Exhibit 65: Data Table on Market opportunity by Distribution Channel ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2023-2028 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2023-2028
o Exhibit 71: Chart on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
o Exhibit 73: Chart on North America – Year-over-year growth 2023-2028 (%)
o Exhibit 74: Data Table on North America – Year-over-year growth 2023-2028 (%)
o 9.4 Europe – Market size and forecast 2023-2028
o Exhibit 75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
o Exhibit 77: Chart on Europe – Year-over-year growth 2023-2028 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
o 9.5 Asia – Market size and forecast 2023-2028
o Exhibit 79: Chart on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 80: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
o Exhibit 81: Chart on Asia – Year-over-year growth 2023-2028 (%)
o Exhibit 82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2023-2028
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
o 9.7 US – Market size and forecast 2023-2028
o Exhibit 87: Chart on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 88: Data Table on US – Market size and forecast 2023-2028 ($ million)
o Exhibit 89: Chart on US – Year-over-year growth 2023-2028 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2023-2028 (%)
o 9.8 Canada – Market size and forecast 2023-2028
o Exhibit 91: Chart on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 92: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
o Exhibit 93: Chart on Canada – Year-over-year growth 2023-2028 (%)
o Exhibit 94: Data Table on Canada – Year-over-year growth 2023-2028 (%)
o 9.9 Germany – Market size and forecast 2023-2028
o Exhibit 95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
o Exhibit 97: Chart on Germany – Year-over-year growth 2023-2028 (%)
o Exhibit 98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
o 9.10 UK – Market size and forecast 2023-2028
o Exhibit 99: Chart on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
o Exhibit 101: Chart on UK – Year-over-year growth 2023-2028 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2023-2028 (%)
o 9.11 China – Market size and forecast 2023-2028
o Exhibit 103: Chart on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 104: Data Table on China – Market size and forecast 2023-2028 ($ million)
o Exhibit 105: Chart on China – Year-over-year growth 2023-2028 (%)
o Exhibit 106: Data Table on China – Year-over-year growth 2023-2028 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ million)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2023 and 2028
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 AstraZeneca Plc
o Exhibit 115: AstraZeneca Plc – Overview
o Exhibit 116: AstraZeneca Plc – Product / Service
o Exhibit 117: AstraZeneca Plc – Key news
o Exhibit 118: AstraZeneca Plc – Key offerings
o 12.4 CSL Ltd.
o Exhibit 119: CSL Ltd. – Overview
o Exhibit 120: CSL Ltd. – Business segments
o Exhibit 121: CSL Ltd. – Key offerings
o Exhibit 122: CSL Ltd. – Segment focus
o 12.5 GlaxoSmithKline Plc
o Exhibit 123: GlaxoSmithKline Plc – Overview
o Exhibit 124: GlaxoSmithKline Plc – Business segments
o Exhibit 125: GlaxoSmithKline Plc – Key news
o Exhibit 126: GlaxoSmithKline Plc – Key offerings
o Exhibit 127: GlaxoSmithKline Plc – Segment focus
o 12.6 MD Total Care LLC.
o Exhibit 128: MD Total Care LLC. – Overview
o Exhibit 129: MD Total Care LLC. – Product / Service
o Exhibit 130: MD Total Care LLC. – Key offerings
o 12.7 Medtronic Plc
o Exhibit 131: Medtronic Plc – Overview
o Exhibit 132: Medtronic Plc – Business segments
o Exhibit 133: Medtronic Plc – Key news
o Exhibit 134: Medtronic Plc – Key offerings
o Exhibit 135: Medtronic Plc – Segment focus
o 12.8 Merck and Co. Inc.
o Exhibit 136: Merck and Co. Inc. – Overview
o Exhibit 137: Merck and Co. Inc. – Business segments
o Exhibit 138: Merck and Co. Inc. – Key news
o Exhibit 139: Merck and Co. Inc. – Key offerings
o Exhibit 140: Merck and Co. Inc. – Segment focus
o 12.9 Novartis AG
o Exhibit 141: Novartis AG – Overview
o Exhibit 142: Novartis AG – Business segments
o Exhibit 143: Novartis AG – Key offerings
o Exhibit 144: Novartis AG – Segment focus
o 12.10 Parkway Holdings Ltd.
o Exhibit 145: Parkway Holdings Ltd. – Overview
o Exhibit 146: Parkway Holdings Ltd. – Product / Service
o Exhibit 147: Parkway Holdings Ltd. – Key offerings
o 12.11 Pfizer Inc.
o Exhibit 148: Pfizer Inc. – Overview
o Exhibit 149: Pfizer Inc. – Product / Service
o Exhibit 150: Pfizer Inc. – Key news
o Exhibit 151: Pfizer Inc. – Key offerings
o 12.12 Regeneron Pharmaceuticals Inc.
o Exhibit 152: Regeneron Pharmaceuticals Inc. – Overview
o Exhibit 153: Regeneron Pharmaceuticals Inc. – Product / Service
o Exhibit 154: Regeneron Pharmaceuticals Inc. – Key offerings
o 12.13 Sanofi
o Exhibit 155: Sanofi – Overview
o Exhibit 156: Sanofi – Business segments
o Exhibit 157: Sanofi – Key news
o Exhibit 158: Sanofi – Key offerings
o Exhibit 159: Sanofi – Segment focus
o 12.14 Teva Pharmaceutical Industries Ltd.
o Exhibit 160: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 161: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 162: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 163: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 164: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.15 The Cleveland Clinic Foundation
o Exhibit 165: The Cleveland Clinic Foundation – Overview
o Exhibit 166: The Cleveland Clinic Foundation – Product / Service
o Exhibit 167: The Cleveland Clinic Foundation – Key offerings
o 12.16 Yashoda Hospitals
o Exhibit 168: Yashoda Hospitals – Overview
o Exhibit 169: Yashoda Hospitals – Product / Service
o Exhibit 170: Yashoda Hospitals – Key offerings
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 171: Inclusions checklist
o Exhibit 172: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 173: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 174: Research methodology
o Exhibit 175: Validation techniques employed for market sizing
o Exhibit 176: Information sources
o 13.5 List of abbreviations
o Exhibit 177: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Distribution Channel
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size – Data Table on global upper respiratory tract infection treatment market 2018 – 2022 ($ million)
Exhibits19: Historic Market Size – Type Segment 2018 – 2022 ($ million)
Exhibits20: Historic Market Size – Distribution Channel Segment 2018 – 2022 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2018 – 2022 ($ million)
Exhibits22: Historic Market Size – Country Segment 2018 – 2022 ($ million)
Exhibits23: Five forces analysis – Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants – Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes – Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry – Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition – Five forces 2023 and 2028
Exhibits30: Chart on Type – Market share 2023-2028 (%)
Exhibits31: Data Table on Type – Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Antibiotics – Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Antibiotics – Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Antibiotics – Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Antibiotics – Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on NSAIDs and nasal decongestants – Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on NSAIDs and nasal decongestants – Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on NSAIDs and nasal decongestants – Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on NSAIDs and nasal decongestants – Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on Others – Market size and forecast 2023-2028 ($ million)
Exhibits43: Data Table on Others – Market size and forecast 2023-2028 ($ million)
Exhibits44: Chart on Others – Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on Others – Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by Type ($ million)
Exhibits47: Data Table on Market opportunity by Type ($ million)
Exhibits48: Chart on Distribution Channel – Market share 2023-2028 (%)
Exhibits49: Data Table on Distribution Channel – Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Distribution Channel
Exhibits51: Data Table on Comparison by Distribution Channel
Exhibits52: Chart on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Hospital pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Hospital pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits57: Data Table on Retail pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits58: Chart on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on Retail pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits60: Chart on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits61: Data Table on Online pharmacies – Market size and forecast 2023-2028 ($ million)
Exhibits62: Chart on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits63: Data Table on Online pharmacies – Year-over-year growth 2023-2028 (%)
Exhibits64: Market opportunity by Distribution Channel ($ million)
Exhibits65: Data Table on Market opportunity by Distribution Channel ($ million)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on North America – Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on North America – Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on North America – Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on North America – Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Europe – Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Europe – Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on Asia – Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on Asia – Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Asia – Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on US – Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on US – Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on US – Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on US – Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada – Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada – Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada – Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany – Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany – Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany – Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on UK – Market size and forecast 2023-2028 ($ million)
Exhibits100: Data Table on UK – Market size and forecast 2023-2028 ($ million)
Exhibits101: Chart on UK – Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2023-2028 (%)
Exhibits103: Chart on China – Market size and forecast 2023-2028 ($ million)
Exhibits104: Data Table on China – Market size and forecast 2023-2028 ($ million)
Exhibits105: Chart on China – Year-over-year growth 2023-2028 (%)
Exhibits106: Data Table on China – Year-over-year growth 2023-2028 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ million)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits109: Impact of drivers and challenges in 2023 and 2028
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: AstraZeneca Plc – Overview
Exhibits116: AstraZeneca Plc – Product / Service
Exhibits117: AstraZeneca Plc – Key news
Exhibits118: AstraZeneca Plc – Key offerings
Exhibits119: CSL Ltd. – Overview
Exhibits120: CSL Ltd. – Business segments
Exhibits121: CSL Ltd. – Key offerings
Exhibits122: CSL Ltd. – Segment focus
Exhibits123: GlaxoSmithKline Plc – Overview
Exhibits124: GlaxoSmithKline Plc – Business segments
Exhibits125: GlaxoSmithKline Plc – Key news
Exhibits126: GlaxoSmithKline Plc – Key offerings
Exhibits127: GlaxoSmithKline Plc – Segment focus
Exhibits128: MD Total Care LLC. – Overview
Exhibits129: MD Total Care LLC. – Product / Service
Exhibits130: MD Total Care LLC. – Key offerings
Exhibits131: Medtronic Plc – Overview
Exhibits132: Medtronic Plc – Business segments
Exhibits133: Medtronic Plc – Key news
Exhibits134: Medtronic Plc – Key offerings
Exhibits135: Medtronic Plc – Segment focus
Exhibits136: Merck and Co. Inc. – Overview
Exhibits137: Merck and Co. Inc. – Business segments
Exhibits138: Merck and Co. Inc. – Key news
Exhibits139: Merck and Co. Inc. – Key offerings
Exhibits140: Merck and Co. Inc. – Segment focus
Exhibits141: Novartis AG – Overview
Exhibits142: Novartis AG – Business segments
Exhibits143: Novartis AG – Key offerings
Exhibits144: Novartis AG – Segment focus
Exhibits145: Parkway Holdings Ltd. – Overview
Exhibits146: Parkway Holdings Ltd. – Product / Service
Exhibits147: Parkway Holdings Ltd. – Key offerings
Exhibits148: Pfizer Inc. – Overview
Exhibits149: Pfizer Inc. – Product / Service
Exhibits150: Pfizer Inc. – Key news
Exhibits151: Pfizer Inc. – Key offerings
Exhibits152: Regeneron Pharmaceuticals Inc. – Overview
Exhibits153: Regeneron Pharmaceuticals Inc. – Product / Service
Exhibits154: Regeneron Pharmaceuticals Inc. – Key offerings
Exhibits155: Sanofi – Overview
Exhibits156: Sanofi – Business segments
Exhibits157: Sanofi – Key news
Exhibits158: Sanofi – Key offerings
Exhibits159: Sanofi – Segment focus
Exhibits160: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits161: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits162: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits163: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits164: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits165: The Cleveland Clinic Foundation – Overview
Exhibits166: The Cleveland Clinic Foundation – Product / Service
Exhibits167: The Cleveland Clinic Foundation – Key offerings
Exhibits168: Yashoda Hospitals – Overview
Exhibits169: Yashoda Hospitals – Product / Service
Exhibits170: Yashoda Hospitals – Key offerings
Exhibits171: Inclusions checklist
Exhibits172: Exclusions checklist
Exhibits173: Currency conversion rates for US$
Exhibits174: Research methodology
Exhibits175: Validation techniques employed for market sizing
Exhibits176: Information sources
Exhibits177: List of abbreviations



❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ 世界の上気道感染症治療市場2024-2028(Global Upper Respiratory Tract Infection Treatment Market 2024-2028)]についてメールでお問い合わせはこちらでお願いします。


◆H&Iグローバルリサーチのお客様(例)◆